周三公布的数据显示，今年第一季度韩国医药产品出口创下历史新高，得益于欧洲市场的强劲需求。

　　韩国健康产业发展研究院（Korea Health Industry Development Institute）的数据显示，今年1月至3月，韩国医药出口达到25.6亿美元的季度新高，同比增长17.7%。

　　特别是，对德国和匈牙利的生物制药产品出口分别比去年同期增加了230%和112%，从而推动该领域的出口大幅增加了30.2%。

　　由于南美和非洲的需求旺盛，疫苗出口也增加了37.7%。

　　与此同时，根据该研究所的数据，今年前三个月，韩国化妆品的出口同比增长12.7%，达到25.8亿美元，是所有季度中第二高的数字。

　　该研究所表示：“对生物制药和基础护肤产品的强劲需求预计将持续到第二季度。”

　　然而，该研究所指出，美国关税政策引发的贸易不确定性可能带来风险。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：于健 SF069

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.